Zobrazeno 1 - 8 of 8 pro vyhledávání: '"Kornmeier CM"'
1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
4
Akademický článek
Investigation of the binding pocket of human hematopoietic prostaglandin (PG) D2 synthase (hH-PGDS): a tale of two waters.
Autor: Trujillo JI; Departments of Medicinal Chemistry, Pfizer Global Research and Development, Chesterfield, MO 63017, United States. john.i.trujillo@pfizer.com, Kiefer JR, Huang W, Day JE, Moon J, Jerome GM, Bono CP, Kornmeier CM, Williams ML, Kuhn C, Rennie GR, Wynn TA, Carron CP, Thorarensen A
Publikováno v: Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2012 Jun 01; Vol. 22 (11), pp. 3795-9. Date of Electronic Publication: 2012 Apr 13.
Zobrazit plný text záznamu
5
Akademický článek
Biochemical, cellular, and anti-inflammatory properties of a potent, selective, orally bioavailable benzamide inhibitor of Rho kinase activity.
Autor: Rajagopalan LE; Department of Discovery Biology, Inflammation Research Unit, Pfizer Global Research and Development, Pfizer Inc., Chesterfield, Missouri 63017, USA. leraja22@gmail.com, Davies MS, Kahn LE, Kornmeier CM, Shimada H, Steiner TA, Zweifel BS, Wendling JM, Payne MA, Loeffler RF, Case BL, Norton MB, Parikh MD, Nemirovskiy OV, Mourey RJ, Masferrer JL, Misko TP, Kolodziej SA
Publikováno v: The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2010 Jun; Vol. 333 (3), pp. 707-16. Date of Electronic Publication: 2010 Mar 12.
Zobrazit plný text záznamu
6
Akademický článek
Discovery of an Oral Potent Selective Inhibitor of Hematopoietic Prostaglandin D Synthase (HPGDS).
Autor: Carron CP; Pfizer Global Research and Development, 700 Chesterfield Parkway West, Chesterfield, Missouri 63017., Trujillo JI; Pfizer Global Research and Development, 700 Chesterfield Parkway West, Chesterfield, Missouri 63017., Olson KL; Pfizer Global Research and Development, 700 Chesterfield Parkway West, Chesterfield, Missouri 63017., Huang W; Pfizer Global Research and Development, 700 Chesterfield Parkway West, Chesterfield, Missouri 63017., Hamper BC; Pfizer Global Research and Development, 700 Chesterfield Parkway West, Chesterfield, Missouri 63017., Dice T; Pfizer Global Research and Development, 700 Chesterfield Parkway West, Chesterfield, Missouri 63017., Neal BE; Pfizer Global Research and Development, 700 Chesterfield Parkway West, Chesterfield, Missouri 63017., Pelc MJ; Pfizer Global Research and Development, 700 Chesterfield Parkway West, Chesterfield, Missouri 63017., Day JE; Pfizer Global Research and Development, 700 Chesterfield Parkway West, Chesterfield, Missouri 63017., Rohrer DC; Pfizer Global Research and Development, 700 Chesterfield Parkway West, Chesterfield, Missouri 63017., Kiefer JR; Pfizer Global Research and Development, 700 Chesterfield Parkway West, Chesterfield, Missouri 63017., Moon JB; Pfizer Global Research and Development, 700 Chesterfield Parkway West, Chesterfield, Missouri 63017., Schweitzer BA; Pfizer Global Research and Development, 700 Chesterfield Parkway West, Chesterfield, Missouri 63017., Blake TD; Pfizer Global Research and Development, 700 Chesterfield Parkway West, Chesterfield, Missouri 63017., Turner SR; Pfizer Global Research and Development, 700 Chesterfield Parkway West, Chesterfield, Missouri 63017., Woerndle R; Pfizer Global Research and Development, 700 Chesterfield Parkway West, Chesterfield, Missouri 63017., Case BL; Pfizer Global Research and Development, 700 Chesterfield Parkway West, Chesterfield, Missouri 63017., Bono CP; Pfizer Global Research and Development, 700 Chesterfield Parkway West, Chesterfield, Missouri 63017., Dilworth VM; Pfizer Global Research and Development, 700 Chesterfield Parkway West, Chesterfield, Missouri 63017., Funckes-Shippy CL; Pfizer Global Research and Development, 700 Chesterfield Parkway West, Chesterfield, Missouri 63017., Hood BL; Pfizer Global Research and Development, 700 Chesterfield Parkway West, Chesterfield, Missouri 63017., Jerome GM; Pfizer Global Research and Development, 700 Chesterfield Parkway West, Chesterfield, Missouri 63017., Kornmeier CM; Pfizer Global Research and Development, 700 Chesterfield Parkway West, Chesterfield, Missouri 63017., Radabaugh MR; Pfizer Global Research and Development, 700 Chesterfield Parkway West, Chesterfield, Missouri 63017., Williams ML; Pfizer Global Research and Development, 700 Chesterfield Parkway West, Chesterfield, Missouri 63017., Davies MS; Pfizer Global Research and Development, 700 Chesterfield Parkway West, Chesterfield, Missouri 63017., Wegner CD; Pfizer Global Research and Development, 700 Chesterfield Parkway West, Chesterfield, Missouri 63017., Welsch DJ; Pfizer Global Research and Development, 700 Chesterfield Parkway West, Chesterfield, Missouri 63017., Abraham WM; Department of Research, Mount Sinai Medical Center, 4300 Alton Road, Miami Beach, Florida 33140., Warren CJ; Pfizer Global Research and Development, 700 Chesterfield Parkway West, Chesterfield, Missouri 63017., Dowty ME; Pfizer Global Research and Development, 700 Chesterfield Parkway West, Chesterfield, Missouri 63017., Hua F; Pfizer Global Research and Development, 700 Chesterfield Parkway West, Chesterfield, Missouri 63017., Zutshi A; Pfizer Global Research and Development, 700 Chesterfield Parkway West, Chesterfield, Missouri 63017., Yang JZ; Pfizer Global Research and Development, 700 Chesterfield Parkway West, Chesterfield, Missouri 63017., Thorarensen A; Pfizer Global Research and Development, 700 Chesterfield Parkway West, Chesterfield, Missouri 63017.
Publikováno v: ACS medicinal chemistry letters [ACS Med Chem Lett] 2010 Feb 02; Vol. 1 (2), pp. 59-63. Date of Electronic Publication: 2010 Feb 02 (Print Publication: 2010).
Zobrazit plný text záznamu
7
Akademický článek
2-Iminopyrrolidines as potent and selective inhibitors of human inducible nitric oxide synthase.
Autor: Hagen TJ; Discovery Medicinal Chemistry, Searle, Monsanto, 4901 Searle Parkway, Skokie, Illinois 60077, Discovery Pharmacology, Searle, Monsanto, 800 North Lindbergh Boulevard, St. Louis, Missouri 63167, USA., Bergmanis AA, Kramer SW, Fok KF, Schmelzer AE, Pitzele BS, Swenton L, Jerome GM, Kornmeier CM, Moore WM, Branson LF, Connor JR, Manning PT, Currie MG, Hallinan EA
Publikováno v: Journal of medicinal chemistry [J Med Chem] 1998 Sep 10; Vol. 41 (19), pp. 3675-83.
Zobrazit plný text záznamu
8
Akademický článek
The glycoprotein alpha-subunit is critical for secretion and stability of the human thyrotropin beta-subunit.
Autor: Matzuk MM; Department of Pharmacology, Washington University School of Medicine, St. Louis, Missouri 63110., Kornmeier CM, Whitfield GK, Kourides IA, Boime I
Publikováno v: Molecular endocrinology (Baltimore, Md.) [Mol Endocrinol] 1988 Feb; Vol. 2 (2), pp. 95-100.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje